首页> 外文OA文献 >Comparison between Tramadol and Pethidine in Patient Controlled Intravenous Analgesia
【2h】

Comparison between Tramadol and Pethidine in Patient Controlled Intravenous Analgesia

机译:曲马多与哌替啶在患者自控静脉镇痛中的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Objective: To compare the efficacy and side effects related to Tramadol with Pethidine in patient controlled intravenous analgesia (PCIA) after total abdominal hysterectomies. Methods: A total of 60 patients were randomized to receive either Tramadol or Pethidine by PCIA (30 in each group) after total abdominal hysterectomy. Pain assessments were recorded one hour after starting the PCIA and then at 6, 12, and 24 hours by using visual analogue scale (VAS). Nausea vomiting score and sedation score were also recorded. Good attempts, total attempts and total drug consumption was noted from PCIA pump at the end of the study period. Results: The analgesia achieved in Tramadol group was comparable to Pethidine. The incidence of nausea and vomiting was similar in both groups. Tramadol causes significantly less sedation than Pethidine (p u3c 0.05). Mean drug consumption, total attempts and good attempts were also significantly less in Tramadol group than Pethidine group (p u3c 0.05). Conclusion: Tramadol produces equivalent analgesia and less sedation and can be used as an alternative to Pethidine in Patient Controlled Intravenous Analgesia for postoperative pain relief after Total Abdominal Hysterectomy (TAH)
机译:目的:比较曲马多联合哌替丁在全腹子宫切除术后患者自控静脉镇痛(PCIA)的疗效和副作用。方法:总共60例患者在全腹子宫切除术后被随机分配接受PCIA曲马多或哌啶(每组30例)。在开始PCIA后1小时记录疼痛评估,然后在6、12和24小时使用视觉模拟量表(VAS)进行疼痛评估。还记录恶心呕吐评分和镇静评分。在研究期结束时,PCIA泵记录了良好的尝试,总的尝试和总的药物消耗。结果:曲马多组的镇痛效果与哌替丁相当。两组的恶心和呕吐发生率相似。曲马多引起的镇静作用明显少于哌替啶(p <0.05)。曲马多组的平均药物消耗,总尝试次数和良好尝试次数也明显低于哌替啶组(p <0.05)。结论:曲马多可产生等效的镇痛作用,镇静作用较小,可作为患者自控静脉镇痛的替代哌啶类药物,用于全腹子宫切除术(TAH)后的术后疼痛缓解

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号